Efficacy of enzalutamide plus androgen deprivation therapy in metastatic hormone-sensitive prostate cancer by pattern of metastatic spread: ARCHES post hoc analyses
Risk of cardiovascular disease following gonadotropinâreleasing hormone agonists vs antagonists in prostate cancer: Realâworld evidence from five databases